SYS ONLINE
Supplements/Compound

MK-677 (Ibutamoren) — Ref

Oral ghrelin mimetic that raises GH/IGF-1 (research reference).

Buy

Overview

Oral ghrelin mimetic that raises GH/IGF-1 (research reference).

Natural sources
  • Endogenously produced or biosynthesized molecule
  • Standardized pharmaceutical- or food-grade supplement
  • Combined with cofactors that improve absorption or activity
Common forms
  • Capsule or softgel
  • Powder
  • Sublingual or buccal
  • Liposomal liquid

Mechanism of action

Ghrelin receptor agonism stimulates pulsatile GH release.

Pathways
  • · Ghrelin receptor agonism stimulates pulsatile GH release

Effects on the body

Increases
lean mass in elderly

Organ system effects

Skeletal Muscle

MK-677 (Ibutamoren) — Ref influences muscle protein synthesis, neuromuscular output, or recovery from exercise.

Evidence-based benefits

Increases lean mass in elderly

Moderate evidence

Potential side effects

Common
  • · Edema
  • · Increased appetite
Rare
  • · CHF in frail patients
Serious
  • · Insulin resistance

Drug interactions

Prescription medications (general)
Always disclose MK-677 (Ibutamoren) — Ref use to your prescriber — additive, antagonistic, or pharmacokinetic interactions are possible.
minor

Supplement interactions

Pairs well with
  • Creatine monohydrate
    Foundational support for strength, power, and lean mass.
  • Whey or EAAs
    Provides amino acid substrate for muscle protein synthesis.
Avoid combining with

No specific avoidances listed.

Dosing & bioavailability

Typical dose
Research only
Best form
Most evidence is based on the capsule or softgel form.
Timing
Consistent daily timing recommended; split larger doses if GI tolerance is a concern.
With food?
With a meal containing fat for fat-soluble compounds; otherwise either.

Where to buy

Affiliate links — we may earn a commission at no extra cost to you. Amazon code supplementsch-20 is auto-applied at checkout. We don't endorse specific brands; verify third-party testing (USP, NSF, Informed Sport) before purchase.

Scientific evidence8Show studies
RCTAnn Intern Med · 2008

MK-677 in frail elderly

Nass R, et al.

1-year DB-RCT in 65 frail elderly.

Key findings

MK-677 raised IGF-1 to young-adult range and increased lean mass.

Open study
Systematic reviewPubMed (NLM) · 1970

PubMed: MK-677 (Ibutamoren) — Ref — Increases lean mass in elderly

Live PubMed search

Live results for "MK-677 (Ibutamoren) — Ref Increases lean mass in elderly" across the PubMed/MEDLINE peer-reviewed index.

Key findings

Opens current human and preclinical literature matching MK-677 (Ibutamoren) — Ref and "Increases lean mass in elderly". Filter by RCT, meta-analysis, or year on the results page.

Open study
Systematic reviewPubMed (NLM) · 1970

PubMed: MK-677 (Ibutamoren) — Ref — randomized controlled trial

Live PubMed search

Live results for "MK-677 (Ibutamoren) — Ref randomized controlled trial" across the PubMed/MEDLINE peer-reviewed index.

Key findings

Opens current human and preclinical literature matching MK-677 (Ibutamoren) — Ref and "randomized controlled trial". Filter by RCT, meta-analysis, or year on the results page.

Open study
Systematic reviewPubMed (NLM) · 1970

PubMed: MK-677 (Ibutamoren) — Ref — meta-analysis

Live PubMed search

Live results for "MK-677 (Ibutamoren) — Ref meta-analysis" across the PubMed/MEDLINE peer-reviewed index.

Key findings

Opens current human and preclinical literature matching MK-677 (Ibutamoren) — Ref and "meta-analysis". Filter by RCT, meta-analysis, or year on the results page.

Open study
Systematic reviewPubMed (NLM) · 1970

PubMed: MK-677 (Ibutamoren) — Ref — pharmacokinetics

Live PubMed search

Live results for "MK-677 (Ibutamoren) — Ref pharmacokinetics" across the PubMed/MEDLINE peer-reviewed index.

Key findings

Opens current human and preclinical literature matching MK-677 (Ibutamoren) — Ref and "pharmacokinetics". Filter by RCT, meta-analysis, or year on the results page.

Open study
Systematic reviewPubMed (NLM) · 1970

PubMed: MK-677 (Ibutamoren) — Ref — safety adverse events

Live PubMed search

Live results for "MK-677 (Ibutamoren) — Ref safety adverse events" across the PubMed/MEDLINE peer-reviewed index.

Key findings

Opens current human and preclinical literature matching MK-677 (Ibutamoren) — Ref and "safety adverse events". Filter by RCT, meta-analysis, or year on the results page.

Open study
Systematic reviewPubMed (NLM) · 1970

PubMed: MK-677 (Ibutamoren) — Ref — dose response

Live PubMed search

Live results for "MK-677 (Ibutamoren) — Ref dose response" across the PubMed/MEDLINE peer-reviewed index.

Key findings

Opens current human and preclinical literature matching MK-677 (Ibutamoren) — Ref and "dose response". Filter by RCT, meta-analysis, or year on the results page.

Open study
Systematic reviewGoogle Scholar · 1970

Google Scholar: MK-677 (Ibutamoren) — Ref — clinical evidence

Live Scholar search

Cross-database citation index for MK-677 (Ibutamoren) — Ref as it relates to "clinical evidence".

Key findings

Includes preprints, theses, and journal articles. Useful for tracking citation counts and follow-on work.

Open study
Educational use only. This profile is not medical advice. Consult a qualified healthcare professional before starting any supplement, especially if you take prescription medication or have a chronic condition.

Community discussion

(0 threads)

Share your experience or read what others have tried. Anecdotes are not medical advice.

Sign in or create a free account to post or reply.
Loading discussion…